Does vitamin D deficiency contribute to fatigue in patients in remission after treatment of gynaecological malignancy.

Phase 4

Completed

• Conditions: vitamine D deficiëntie.; Hypovitaminosis D; Vitamin D shortage; 10038597

• Registration Number: NL-OMON35405
• Lead Sponsor: Meander Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 292

Inclusion Criteria

Patients in remission after successful treatment of a gynaecological malignancy: ovary carcinoma, endometrial carcinoma, cervical carcinoma, tubal carcinoma or vulva carcinoma who visit the gynaecological oncological outpatients clinic of Meander Medisch Centrum in Amersfoort.;Remission is defined as a disease free status of at least 6 months after termination of the treatment.

Exclusion Criteria

-Patients with relapsing disease after initial successful treatment of a gynaecological malignancy.
-Patients with relapsing disease during the study period or within 3 months after inclusion after initial successful treatment of a gynaecological malignancy.
-Patients with renal failure; by definition a MDRD < 60 ml/min, because of the reduced effectiveness of 25(OH)vitamine D.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>-Vitamin D level at t=0 and t=2 months.<br /><br>-Score on fatigue questionnaire at t=0 and t=2 months.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>